about
Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.Ileal inflammation may trigger the development of GP2-specific pancreatic autoantibodies in patients with Crohn's disease.Improved outcome of severe acute pancreatitis in the intensive care unit.Aspirin Induced Adverse Effects on the Small and Large Intestine.An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment.A young man with bowel obstruction and cachexia.Anti-GP2 antibodies in inflammatory bowel disease patients with ileal pouch.Splitting a therapeutic dose of thioguanine may avoid liver toxicity and be an efficacious treatment for severe inflammatory bowel disease: a 2-center observational cohort study.Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.Early change in faecal calprotectin predicts primary non-response to anti-TNFα therapy in Crohn's disease.Gastrointestinal toxicity of immune checkpoint inhibitors: from mechanisms to management.Antitumor necrosis α treatment in primary sclerosing cholangitis associated inflammatory bowel disease after liver transplantation.Complement receptor CD46 co-stimulates optimal human CD8 T cell effector function via fatty acid metabolismAntibodies to glycoprotein 2 (GP2) in patients with inflammatory bowel diseases from UKDiagnostic and clinical significance of Crohn's disease-specific pancreatic anti-GP2 and anti-CUZD1 antibodiesCholestyramine treats primary sclerosing cholangitis-associated inflammatory bowel diseaseA new form of chronic inflammatory bowel disease associated with chronic liver diseaseVedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case SeriesLetter: vedolizumab for autoimmune liver disease associated inflammatory bowel diseaseGastric Lesion in a Patient With Lynch SyndromeGolimumab: early experience and medium-term outcomes from two UK tertiary IBD centresDepressive symptoms in inflammatory bowel disease: an extraintestinal manifestation of inflammation?Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
P50
Q34367414-580761E7-39F3-4D7B-BD74-CF24DCDB4D42Q35523768-3384CF12-B9D1-4B7C-A32F-39F602F1C931Q35724871-B2C31FFD-5403-4C9E-8154-60210A0A0CDFQ36251799-443D7C1B-D03A-4BE6-ADC8-B7A51BB01871Q36355419-50F322E4-0A76-4A65-88C7-848C198EC1F4Q36676652-93E70725-35FB-41AF-8C5E-D7AD02A3AB12Q38586666-6611D886-3B32-4F6B-B7AE-85815392ADA5Q41139626-D0004181-60B6-4926-B6CF-906080850A50Q42581109-F302474A-A2C0-4518-B0F4-97431A2DF795Q44168214-95248CD2-A270-48FD-8155-AF966ABA8222Q44577440-1D097205-2EF6-485D-AC63-4577F14782DCQ50238188-C40820F6-8FFB-44EF-BD5C-1CC40947EF3CQ51649850-C19E39B2-ADF7-41B5-94FB-86B51EF1FAB8Q52728313-42032CD0-D44D-4A01-A94C-6AC19FF18560Q53426230-2F5B0D2F-5EEF-47F6-81D8-79FDB4C02A51Q57285482-D3E2C883-51BE-4DBB-A335-04B2D5BD64F7Q83431718-362CB72C-DD6D-46EC-A26F-D4BE9E5ABD21Q86095389-1EBBB5EB-549F-4EC5-AEF1-A90919CCF2EEQ86321731-E70DDEF7-2228-4E8F-BA84-3FD7E9007663Q87009925-947FA986-E9FA-48CF-874B-78F4F295AD83Q88192479-BF5AD4E5-0541-41B6-9BB1-17A2FE41BBB6Q88418465-6FD80866-BCB1-4F64-BEF2-E8E2C6F08EA6Q88431017-435B26F5-952F-4BAF-93BE-6CF48F7D98EBQ90485728-8DCF9AF1-DF1B-40A6-BE73-15175F60E36FQ91575054-4927C181-1778-4050-9106-57D84072EE8FQ91618743-C70B0B15-752E-4CBD-9904-E48AB1358B41
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Polychronis Pavlidis
@ast
Polychronis Pavlidis
@en
Polychronis Pavlidis
@es
Polychronis Pavlidis
@nl
Polychronis Pavlidis
@sl
type
label
Polychronis Pavlidis
@ast
Polychronis Pavlidis
@en
Polychronis Pavlidis
@es
Polychronis Pavlidis
@nl
Polychronis Pavlidis
@sl
prefLabel
Polychronis Pavlidis
@ast
Polychronis Pavlidis
@en
Polychronis Pavlidis
@es
Polychronis Pavlidis
@nl
Polychronis Pavlidis
@sl
P106
P1153
37261719700
P31
P496
0000-0003-4864-2208